Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $80,650
Award facts
- Contract value 100% obligated
- $80,649.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DOVATO 50-300 mg tablets (30-count packaging) in the amount of $80,649.98 under a firm fixed-price contract type. The award was issued on January 20, 2026, with an ultimate completion date of January 21, 2026, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award supports the delivery of DOVATO, an antiretroviral medication, continuing the company's role as a key supplier of essential prescription medications and medical commodities to support military personnel and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQU8M?
SPE2DR26FQU8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU8M worth?
The government has obligated $80,650 on SPE2DR26FQU8M.
Is contract SPE2DR26FQU8M an order under another contract?
Yes. SPE2DR26FQU8M is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU8M competed?
The extent of competition for SPE2DR26FQU8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award